Physician profile
Michael Adams
NPI 1336637404
$862.70
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $721 · 2022: $62.06 · 2024: $79.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $276.94 | 2021-2022 | |
| Eisai INC. | $171.10 | 2021 | |
| Alkermes, INC. | $108.25 | 2021 | |
| Jazz Pharmaceuticals INC. | $85.40 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $79.55 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $62.46 | 2021 | |
| Neos Therapeutics, LP | $23.45 | 2021 | |
| Bausch Health US, LLC | $21.42 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.21 | 2021 | |
| Medline Industries LP | $12.92 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Adams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.